These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9346599)

  • 1. Neurological and psychiatric complications associated with immunosuppression in liver transplantation.
    Lucey MR
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):39-44. PubMed ID: 9346599
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression in liver transplantation: monitoring, dose adjustment, reduction, and withdrawal.
    Wall WJ; Ghent CN
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):3-10. PubMed ID: 9346595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is immune tolerance just a chimera?].
    Fasoli G
    G Ital Nefrol; 2008; 25(3):272. PubMed ID: 18473293
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of immunosuppression on growth and development.
    Balistreri WF; Bucuvalas JC; Ryckman FC
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):64-73. PubMed ID: 9346602
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing perspectives on the role of corticosteroids after liver transplantation.
    Lucey MR
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S58-63. PubMed ID: 10431018
    [No Abstract]   [Full Text] [Related]  

  • 6. The protective effect of the liver: does it apply to the bowel too?
    Pirenne J; Kawai M
    Transplantation; 2006 Apr; 81(7):978-9. PubMed ID: 16612270
    [No Abstract]   [Full Text] [Related]  

  • 7. Perioperative and postoperative use of immunosuppressive agents in liver transplantation.
    Krok KL; Thuluvath PJ
    Int Anesthesiol Clin; 2006; 44(3):51-68. PubMed ID: 16832206
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of antilymphocyte induction therapy in liver transplantation.
    Wall WJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppression by individual need. Protection for the donor kidney].
    MMW Fortschr Med; 2002 Jan; 144(3-4):58. PubMed ID: 11862795
    [No Abstract]   [Full Text] [Related]  

  • 10. [Operational tolerance in liver transplantation is more frequent than expected and increases with time after the intervention].
    Pons Miñano JA
    Gastroenterol Hepatol; 2013 Nov; 36(9):551-4. PubMed ID: 24029172
    [No Abstract]   [Full Text] [Related]  

  • 11. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
    Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
    Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy.
    Bishop GA; McCaughan GW
    Liver Transpl; 2001 Mar; 7(3):161-72. PubMed ID: 11244155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
    de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
    Langrehr JM; Neuhaus PJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
    Ganschow R; Albani J; Grabhorn E; Richter A; Burdelski M
    Pediatr Transplant; 2006 Mar; 10(2):220-4. PubMed ID: 16573611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new immunosuppressive era.
    Lo Monte AI; Ciancio G; Burke G; Roth D; Miller J
    Ann Ital Chir; 1999; 70(1):1-19. PubMed ID: 10367502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique aspects of rejection and tolerance in liver transplantation.
    Knechtle SJ; Kwun J
    Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cells.
    Donckier V; Craciun L; Lucidi V; Buggenhout A; Troisi R; Rogiers X; Boon N; Gustot T; Moreno C; Bourgeois N; Colle I; Van Vlierberghe H; Nagy N; Praet M; Dernies T; Amrani M; Stordeur P; de Hemptinne B; Goldman M
    Transplantation; 2009 May; 87(9 Suppl):S91-5. PubMed ID: 19424019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral immunity and kidney transplantation. Possibilities and desensitizing treatment].
    Rowshani AT; Lardy NM; Surachno JS; ten Berge RJ
    Ned Tijdschr Geneeskd; 2009 Mar; 153(13):612-6. PubMed ID: 19408538
    [No Abstract]   [Full Text] [Related]  

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.